LendingClub Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LendingClub Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $314.70M | Mar 11, 2021 |
| FY2019 | Dec 31, 2019 | $188.49M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $204.90M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $190.81M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $174.42M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $181.52M | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | $184.65M | Feb 19, 2020 |
| FY2019 | Jun 30, 2018 | $176.98M | Feb 19, 2020 |
| FY2019 | Mar 31, 2018 | $151.67M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $156.46M | Feb 20, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $604.23M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $530.59M | Feb 19, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $135.68M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $51.33M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $38.94M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $289.69M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $18.58M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | ($187.54M) | Feb 9, 2023 |
| FY2019 | Dec 31, 2019 | $234.0K | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | ($383.0K) | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | ($10.66M) | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | ($19.94M) | Feb 19, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $139.05M | Mar 11, 2021 |
| FY2019 | Dec 31, 2019 | $41.08M | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | $41.46M | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | $43.30M | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | $42.55M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $39.55M | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | $41.22M | Feb 19, 2020 |
| FY2019 | Jun 30, 2018 | $37.65M | Feb 19, 2020 |
| FY2019 | Mar 31, 2018 | $36.84M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $37.93M | Feb 20, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.73B) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($2.63B) | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | ($1.14B) | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $375.57M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $239.87M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $418.03M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | ($270.64M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | ($639.74M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | ($573.39M) | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $545.0K | Feb 20, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $140.34M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $54.30M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $59.51M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $69.48M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $34.41M | Feb 16, 2024 |
| FY2022 | Dec 31, 2020 | $31.15M | Feb 9, 2023 |
| FY2021 | Dec 31, 2019 | $50.67M | Feb 11, 2022 |
| FY2020 | Dec 31, 2018 | $52.98M | Mar 11, 2021 |
| FY2019 | Dec 31, 2017 | $44.62M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $51.84M | Feb 20, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.57B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $10.63B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $8.83B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $7.98B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.90B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $1.86B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $2.98B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $3.82B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $4.64B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $5.56B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.07B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $9.29B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $7.58B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $6.82B | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $4.05B | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $1.14B | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | $2.08B | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $2.95B | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $3.71B | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $4.59B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.50B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.25B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $1.16B | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $850.24M | Feb 13, 2025 |
| FY2019 | Dec 31, 2019 | $900.19M | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $869.20M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $922.50M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $975.77M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $1.04B | Feb 28, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $75.72M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $75.72M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $75.72M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $75.72M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | $75.72M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Feb 11, 2022 |
| FY2019 | Dec 31, 2019 | $0 | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | $0 | Feb 19, 2020 |
| FY2019 | Dec 31, 2017 | $35.63M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $35.63M | Feb 20, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($201.80M) | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | ($337.48M) | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | ($388.81M) | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | ($427.75M) | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | ($717.43M) | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | ($786.21M) | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | ($548.47M) | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | ($517.73M) | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | ($389.42M) | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | ($234.19M) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $524.96M | Mar 11, 2021 |
| FY2020 | Dec 31, 2019 | $243.78M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | $372.97M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | $401.72M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | $515.60M | Feb 22, 2018 |
| FY2017 | Dec 31, 2015 | $623.53M | Feb 22, 2018 |
| FY2017 | Dec 31, 2014 | $869.78M | Feb 22, 2018 |
| FY2016 | Dec 31, 2013 | $49.30M | Feb 28, 2017 |
| FY2015 | Dec 31, 2012 | $52.55M | Feb 22, 2016 |
| FY2014 | Mar 31, 2012 | $31.24M | Feb 27, 2015 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $19.35M | Feb 13, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 13, 2025 |
| FY2019 | Dec 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 19, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 13, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 11, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 19, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 115.37M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 113.38M | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 110.41M | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | 106.55M | Feb 16, 2024 |
| FY2022 | Dec 31, 2021 | 101.04M | Feb 9, 2023 |
| FY2021 | Dec 31, 2020 | 88.15M | Feb 11, 2022 |
| FY2020 | Dec 31, 2019 | 88.76M | Mar 11, 2021 |
| FY2019 | Dec 31, 2018 | 85.93M | Feb 19, 2020 |
| FY2018 | Dec 31, 2017 | 417.47M | Feb 20, 2019 |
| FY2017 | Dec 31, 2016 | 397.98M | Feb 22, 2018 |